Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeting glycodeoxycholic acid as a therapeutic strategy in type 2 diabetes mellitus
2017-002079-24Phase 4Active
- Sponsor
- Academic Medical Center
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of glycodeoxycholic acid in type 2 diabetes mellitus (T2DM) and hyperlipidemia (2 arms), sponsored by Academic Medical Center. Primary endpoint: Safety of long-term glycodeoxycholic acid administration in healthy volunteers. Started Jun 2017; status: active.
02
Drugs
glycodeoxycholic acid
03
Conditions
type 2 diabetes mellitus (T2DM)hyperlipidemia
Beyond the preview
Go deeper on 2017-002079-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002079-24.